Prospective evaluation of plasma lactate parameters for prognosticating dogs with shock

Evaluation of Blood Lactate, Heart Rate, Blood Pressure, and Shock Index, and Their Association with Prognosis in Calves

Diseases in young calves received as emergencies are often associated with hypovolemic and/or septic shocks. The objectives of our study were to (1) assess the correlation between clinical hemodynamic parameters and blood L-lactates (LAC), systolic blood pressure (SBP), and the shock index (SI) recorded upon arrival; and (2) to evaluate how these parameters were related to short-term outcomes in calves under 4 months of age presented as emergencies. We conducted a single-observer prospective observational study on calves aged from 1 day to 4 months, presented to the Veterinary Clinic for Ruminants of Liège from December 2020 to May 2022. Forty-five calves were included in the study. The statistical analysis revealed a significant correlation between LAC and heart rate (r = 0.570; p < 0.05) and LAC and SI (r = 0.373; p < 0.05). A high LAC value at admission was significantly associated with a negative outcome (death) (p < 0.05). In calves suffering from obstructive digestive diseases, the SI was related to the outcome and the analysis indicated a cut-off value of 1.13 (Se = 0.77, Spe = 1). In conclusion, in our study, the initial blood L-lactate value was correlated with heart rate, the shock index, and the clinical shock score, and admission hyperlactatemia was associated with a poor prognosis in calves under 4 months of age. In this cohort, the shock index in calves suffering from digestive diseases was linked with mortality.

Evaluation of plasma lactate parameters for predicting mortality of septic patients

Objective

To compare the accuracy of serum lactate parameters, including lactate peak concentration (LACpeak), lactate time area (LACarea), and lactate clearance (LC) for predicting mortality of the septic patients, and to compare with the predictive accuracy of National Early Warning Score (NEWS) and Sequential Organ Failure Assessment (SOFA) scores.

Methods

This study retrospectively screened the septic patients admitted to the ICU in the Medical Information Mart for Intensive Care IV (MIMIC-IV) from 2008 to 2019. The baseline data and outcomes of patients were gathered. The subjects were divided into the non-survival group and the survival group. SOFA, NEWS, LACpeak, and LACarea were recorded. The LC was calculated 6 h after LACpeak. The above parameters were compared by the T-test and Mann-Whitney U test, and odds ratios were calculated adjusting for age and sex. The receiver operating characteristic curves (ROCs) of subjects were plotted according to SOFA, NEWS, LACpeak, and LACarea within 24h, and LC at 6h of ICU admission. The Areas under the ROC curve (AUCs), sensitivity, and specificity were compared with R version 4.1.1.

Results

1,169 septic patients were involved, and 366 (31.3%) patients died within 28 days. Compared to the survival group, the LACpeak of the non-survival group was higher [4.85 (3.2, 7.9) vs. 3.4 (2.6, 5.25) mmol/L, adjusted odds ratio 1.18, P < 0.001], and the LACarea of the non-survivals was higher than the survivals too [18.44 (10.36, 27.63) vs. 13.65 (9.01, 21.73), adjusted odds ratio 1.03, P < 0.001)]. The LC of the survivals at 6 h after LACpeak was significantly higher than that of the non-survivals [0.26 (0.14.0.42) vs. 0.19 (0.10, 0.33), adjusted odds ratio 0.06, P < 0.01]. Within 24h of ICU admission, the AUCs of mortality prediction in descending order were NEWS [0.73 (0.70, 0.76)], SOFA [0.69 (0.66, 0.73)], LACpeak [0.64 (0.61, 0.68)], and LACarea [0.60 (0.56, 0.63)]. There were 204 patients with 6-hour LC after LACpeak the AUCs of LACarea, LACpeak and LC were 0.73(0.65, 0.80), 0.71(0.62,0.78) and 0.65 (0.56, 0.73), respectively.

Conclusions

The predictive accuracy of LC was not superior to LACpeak and LACarea for the mortality of the septic patients and the predictive value of all the above lactate parameters for mortality maybe not better than SOFA and NEWS.

Effects and safety of extracorporeal membrane oxygenation in the treatment of patients with ST-segment elevation myocardial infarction and cardiogenic shock: A systematic review and meta-analysis

Background

There is a lack of large randomized controlled trials (RCTs) that comprehensively evaluate the effects of venoarterial extracorporeal membrane oxygenation (V-A ECMO)- assisted treatment of patients with ST-segment elevation myocardial infarction (STEMI) combined with Cardiogenic shock (CS). This meta-analysis aims to identify predictors of short-term mortality, and the incidence of various complications in patients with STEMI and CS treated with V-A ECMO.

Methods

We searched PubMed, Cochrane Library, Web of Science, Embase, China National Knowledge Infrastructure (CNKI), and the Wanfang Database from 2008 to January 2022 for studies evaluating patients with STEMI and CS treated with V-A ECMO. Studies that reported on mortality in ≥ 10 adult (>18 years) patients were included. Newcastle-Ottawa Scale was used by two independent reviewers to assess methodological quality. Mantel-Haenszel models were used to pool the data for meta-analysis.

Results

Sixteen studies (1,162 patients) were included with a pooled mortality estimate of 50.9%. Age > 65 years, BMI > 25 kg/m², lactate > 8 mmol/L, anterior wall infarction, longer CPR time, and longer time from arrest to extracorporeal cardiopulmonary resuscitation (ECPR) were risk predictors of mortality. Achieving TIMI-3 flow after percutaneous coronary intervention (PCI) was a protective factor of mortality. The prevalence of bleeding, cerebral infarction, leg ischemia, and renal failure were 22, 9.9, 7.4, and 49.4%, respectively.

Conclusion

Our study identified Age, BMI, lactate, anterior wall infarction, TIMI-3 flow after PCI, CPR time, and time from arrest to ECPR significantly influence mortality in STEMI patients with CS requiring V-A ECMO. These factors may help clinicians to detect patients with poor prognoses earlier and develop new mortality prediction models.

[Not Available]

In der Humanmedizin ist die Hyperlaktatämie bei Intensivpatienten mit erhöhter Mortalität assoziiert und wird in der Notfallmedizin als prognostischer Parameter genutzt. Beim Hund besitzen initial erhöhte Plasmalaktatwerte bei verschiedenen Erkrankungen (u. a. immunmediierte Anämie, Magendrehung, Babesiose, SIRS und septische Peritonitis) prognostische Wertigkeit. Ziel der Studie war es, den klinischen Nutzen der initialen Plasmalaktatkonzentration, serieller Laktatwerte sowie der Laktat-Clearance bezüglich des Einflusses auf die Mortalität bei Hunden mit Schockgeschehen zu untersuchen.